H.C. Wainwright initiated coverage of Vertical Aerospace (EVTL) with a Buy rating and $12 price target The company specializes in designing ...

H.C. Wainwright lowered the firm’s price target on Neurocrine (NBIX) to $185 from $190 and keeps a Buy rating on the shares. FY25 Ingrezza ...

Adicet Bio (NASDAQ:ACET – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. A number of other ...

H.C. Wainwright analyst Mike Colonnese reiterated the Buy rating on CleanSpark, Inc. (NASDAQ:CLSK), with a price forecast of ...

H.C. Wainwright analyst Mitchell S. Kapoor revised the price target on Alumis Inc (NASDAQ:ALMS) to $19.00, down from the previous target of $26.00, while retaining a Buy rating for the company's ...

Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...

Research analysts at StockNews.com initiated coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the specialty pharmaceutical ...

In this article, we will discuss the 12 Best Healthcare Stocks to Buy According to Analysts. McKinsey reported that, since ...

CFO Gary Vecchiarelli reported that Q1 revenues grew 120% year-over-year to $162.3 million, driven by higher Bitcoin prices and increased production efficiency. Fleet efficiency improved to 17.59 ...